WARS1

WARS1

<div class="infobox infobox-gene">
<div class="infobox-header">WARS1</div>

Overview

WARS1 is a human gene whose product encodes tryptophanyl-tRNA synthetase 1 (TrpRS), an enzyme essential for protein synthesis. This enzyme catalyzes the attachment of tryptophan to its cognate tRNA, a critical step in translation. Aminoacyl-tRNA synthetases also have diverse extra-translational functions including RNA splicing, cell signaling, and immune regulation[@sissler2017]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration and neurodevelopment.

<table class="infobox-table">
<tr><th>Gene Symbol</th><td>WARS1</td></tr>
<tr><th>Full Name</th><td>Tryptophanyl-tRNA Synthetase 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q32.13</td></tr>
<tr><th>NCBI Gene ID</th><td>[10335](https://www.ncbi.nlm.nih.gov/gene/10335)</td></tr>
<tr><th>OMIM</th><td>[191052](https://www.omim.org/entry/191052)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000124608](https://ensembl.org/Homo_species/Gene/Summary?g=ENSG00000124608)</td></tr>
<tr><th>UniProt</th><td>[P23381](https://www.uniprot.org/uniprotkb/P23381/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Neurodevelopmental disorders, Charcot-Marie-Tooth disease type 2F, hereditary spastic paraplegia, sensorineural hearing loss</td></tr>
</table>
</div>

Summary

WARS1

<div class="infobox infobox-gene">
<div class="infobox-header">WARS1</div>

Overview

WARS1 is a human gene whose product encodes tryptophanyl-tRNA synthetase 1 (TrpRS), an enzyme essential for protein synthesis. This enzyme catalyzes the attachment of tryptophan to its cognate tRNA, a critical step in translation. Aminoacyl-tRNA synthetases also have diverse extra-translational functions including RNA splicing, cell signaling, and immune regulation[@sissler2017]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration and neurodevelopment.

<table class="infobox-table">
<tr><th>Gene Symbol</th><td>WARS1</td></tr>
<tr><th>Full Name</th><td>Tryptophanyl-tRNA Synthetase 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q32.13</td></tr>
<tr><th>NCBI Gene ID</th><td>[10335](https://www.ncbi.nlm.nih.gov/gene/10335)</td></tr>
<tr><th>OMIM</th><td>[191052](https://www.omim.org/entry/191052)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000124608](https://ensembl.org/Homo_species/Gene/Summary?g=ENSG00000124608)</td></tr>
<tr><th>UniProt</th><td>[P23381](https://www.uniprot.org/uniprotkb/P23381/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Neurodevelopmental disorders, Charcot-Marie-Tooth disease type 2F, hereditary spastic paraplegia, sensorineural hearing loss</td></tr>
</table>
</div>

Summary

WARS1 encodes tryptophanyl-tRNA synthetase 1 (TrpRS), which catalyzes tryptophan incorporation into proteins during translation[@sissler2017]. Biallelic pathogenic variants cause a syndrome characterized by microcephaly, neurodevelopmental delay, and peripheral neuropathy (sometimes called "Warburg Micro syndrome" or related disorders)[@yang2019]. Heterozygous dominant variants cause Charcot-Marie-Tooth disease type 2F (CMT2F) and hereditary spastic paraplegia[@kim2020][@liu2021]. WARS1 is one of several aminoacyl-tRNA synthetases (ARS) linked to neurological diseases, highlighting the importance of translational machinery in neuronal health[@antonellis2019].

Normal Function

Enzymatic Activity

WARS1 encodes tryptophanyl-tRNA synthetase (TrpRS), a member of the class I aminoacyl-tRNA synthetase family[@sissler2017]. The enzyme catalyzes the following reaction:

Tryptophan + tRNA(Trp) + ATP → Tryptophanyl-tRNA(Trp) + AMP + PPi

This aminoacylation reaction is essential for translational fidelity and efficiency. TrpRS performs this function in both the cytoplasm and mitochondria[@sissler2017].

Protein Structure

Human TrpRS is a 471-amino acid protein (UniProt P23381) composed of:

• N-terminal domain (residues 1-250): Contains the catalytic core with the class I signature motifs (KMSKS and HIGH motifs)
• C-terminal domain (residues 250-471): Mediates dimerization and contains the tRNA-binding region
• EMSA2 domain (in some isoforms): Additional regulatory domain involved in cellular signaling

Extra-Translational Functions

Beyond protein synthesis, TrpRS has several extra-translational functions[@beyer2019]:

These moonlighting functions may contribute to the tissue-specific phenotypes observed in WARS1-related diseases[@beyer2019].

Disease Associations

WARS1-Related Neurodevelopmental Disorder

Biallelic (homozygous or compound heterozygous) pathogenic variants in WARS1 cause a syndrome characterized by[@yang2019][@muller2019]:

• Microcephaly: Reduced head circumference, often severe
• Neurodevelopmental delay: Global developmental delay, intellectual disability
• Peripheral neuropathy: Motor and sensory deficits
• Seizures: In some patients
• Hypotonia: Reduced muscle tone
• Growth retardation: Poor overall growth

Charcot-Marie-Tooth Disease Type 2F (CMT2F)

Heterozygous dominant WARS1 variants cause CMT2F, an autosomal dominant peripheral neuropathy characterized by[@kim2020]:

• Motor symptoms: Weakness and atrophy of distal muscles
• Sensory deficits: Reduced sensation, especially in feet and hands
• Onset: Typically in adolescence or early adulthood
• Progression: Gradual deterioration over decades

Hereditary Spastic Paraplegia (HSP)

Specific WARS1 variants cause a pure form of hereditary spastic paraplegia[@liu2021]:

• Lower limb spasticity: Progressive stiffness and weakness
• Hyperreflexia: Exaggerated deep tendon reflexes
• Bladder dysfunction: In some cases
• Onset: Variable, often in childhood or adolescence

Sensorineural Hearing Loss

Pathogenic WARS1 variants have been associated with sensorineural hearing loss[@wetzmann2020]:

• Bilateral hearing loss: Typically severe to profound
• Cochlear involvement: Often cochlear in origin
• Syndromic: May occur with other features like neuropathy

Pathogenic Mechanisms

Several mechanisms have been proposed for WARS1-associated disease[@ijspeert2021]:

Studies suggest that disease mechanisms vary by variant type and inheritance pattern[@ijspeert2021].

Expression Patterns

WARS1 is expressed ubiquitously across all tissues, with highest expression in[@sissler2017]:

• Central nervous system: Cerebral cortex, hippocampus, cerebellum, and spinal cord
• Peripheral nervous system: Dorsal root ganglia and peripheral nerves
• Inner ear: Cochlea and vestibular system (explaining hearing loss in some patients)
• Skeletal muscle: Postnatal muscle development and maintenance
• Heart: Cardiac muscle tissue
• Liver: Hepatocytes

Animal Models

Mouse Models

Several mouse models have been generated to study WARS1-related disease:

• Wars1^+/-: Heterozygous knock-in mice develop peripheral neuropathy with age
• Wars1^-/-: Homozygous knockout is embryonic lethal, demonstrating essential function

Zebrafish Models

Zebrafish studies have shown that morpholino-mediated knockdown of wars leads to[@suzuki2022]:

• Microcephaly
• Motor axon pathfinding defects
• Peripheral nerve abnormalities
• Reduced motor neuron viability

Patient-Derived Models

• Patient-derived fibroblasts: Show altered mitochondrial function and stress responses[@zhang2022]
• iPSC-derived neurons: Demonstrate axonal growth defects and altered neuronal morphology[@park2023]
• CRISPR-edited cell lines: Isogenic controls for mechanism studies

Genetics and Variants

Known Pathogenic Variants

Over 40 pathogenic variants in WARS1 have been identified in patients with various neurological disorders[@ijspeert2021]. Common mutation types include:

• Missense mutations: The majority of pathogenic variants are missense changes
• Nonsense mutations: Cause premature termination, leading to truncated proteins
• Frameshift mutations: Lead to altered protein sequence and premature termination
• Splice-site mutations: Lead to exon skipping or intron retention

Genotype-Phenotype Correlation

Studies have shown that specific WARS1 variants are associated with varying phenotypes[@yang2019][@muller2019]:

• Biallelic variants: Typically cause severe neurodevelopmental syndrome with microcephaly
• Heterozygous dominant variants: Cause CMT2F or hereditary spastic paraplegia
• Specific missense variants: Associated with sensorineural hearing loss

Variant Frequencies

WARS1 pathogenic variants are rare in the general population:

• Carrier frequency: ~1 in 200,000 for most variants
• Founder mutations identified in specific populations

Therapeutic Approaches

Small Molecule Therapies

• Protein folding correctors: Compounds that restore proper folding of mutant TrpRS
• Stabilizing agents: Molecules that stabilize the wild-type/mutant protein
• Mitochondrial function enhancers: Drugs targeting mitochondrial dysfunction

Gene Therapy Approaches

• Allele-specific silencing: siRNA or antisense oligonucleotides targeting mutant allele
• CRISPR-based editing: Prime editing and base editing approaches to correct specific mutations
• Gene replacement: Delivering wild-type WARS1 to affected tissues (challenging due to dominant mechanism in some cases)

Symptomatic Treatments

• Physical therapy and occupational therapy
• Orthopedic devices (braces, custom footwear)
• Hearing aids for sensorineural hearing loss
• Antiepileptic drugs for seizures
• Pain management for neuropathic pain

Diagnosis

Clinical Presentation

Patients with WARS1-related disorders present with variable features depending on the specific variant:

• Severe microcephaly
• Global developmental delay/intellectual disability
• Peripheral neuropathy
• Hypotonia
• Seizures (in some cases)

• Progressive distal motor and sensory neuropathy
• Onset in adolescence or early adulthood
• Family history consistent with autosomal dominant inheritance

• Progressive lower limb spasticity
• Hyperreflexia
• Variable sensory involvement

Diagnostic Workup

• Sequencing: Whole exome sequencing or targeted panel
• Confirmation: Sanger sequencing for variant confirmation
• Interpretation: Classification as pathogenic/likely pathogenic

• Reduced motor nerve conduction velocities
• Reduced compound muscle action potential amplitudes

• MRI: May show brain malformations, particularly microcephaly
• MRI of the spine: May show cord atrophy in HSP

• Pure tone audiometry
• Auditory brainstem responses

Differential Diagnosis

WARS1-related disorders must be distinguished from:

• Other forms of CMT (CMT1A, CMT2A, CMTX)
• Other neurodevelopmental disorders with microcephaly
• Other forms of hereditary spastic paraplegia
• Other causes of sensorineural hearing loss

Epidemiology

Prevalence

WARS1-related disorders are rare:

• Overall estimate: 1 in 500,000 to 1 in 1,000,000
• CMT2F: WARS1 accounts for approximately 1-2% of CMT2 cases
• Hereditary spastic paraplegia: WARS1 accounts for a small fraction of all HSP cases

Demographics

• Onset age: Variable by condition (infancy for neurodevelopmental, adolescence/adulthood for CMT2F/HSP)
• Sex distribution: Equal male and female affected
• Ethnic distribution: No specific ethnic predominance; founder mutations identified in some populations

Inheritance

• Neurodevelopmental syndrome: Autosomal recessive (biallelic variants)
• CMT2F: Autosomal dominant (heterozygous variants)
• Hereditary spastic paraplegia: Usually autosomal dominant
• Penetrance: Near complete for most pathogenic variants

Molecular Mechanisms

WARS1 in Protein Synthesis

Disease Mechanisms

Interacting Proteins

• YARS2 (tyrosyl-tRNA synthetase 2): Mitochondrial tyrosyl-tRNA synthetase, interacts in mitochondrial translation
• EF-Tu (elongation factor Tu): Essential for delivery of aminoacyl-tRNA to the ribosome
• EF-G (elongation factor G): Works in concert with EF-Tu for ribosomal translocation
• Aminoacyl-tRNA synthetase complex: Multi-ARS complex that may coordinate translational regulation
• Mitochondrial aminoacyl-tRNA synthetases: Component of mitochondrial translation machinery
• Ribosomal proteins: Interaction with both cytoplasmic and mitochondrial ribosomes
• Hsp90: Molecular chaperone involved in folding and stabilization of TrpRS

Key Publications

Related Conditions

• [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease) (CMT)
• [Hereditary spastic paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Microcephaly](/diseases/microcephaly)
• [Sensorineural hearing loss](/diseases/sensorineural-hearing-loss)
• [Neurodevelopmental disorders](/diseases/neurodevelopmental-disorders)
• Other ARS-related diseases: [GARS1](/genes/gars1) (CMT2D), [AARS1](/genes/aars1) (CMT2N), [YARS2](/genes/yars2) (myopathy, lactic acidosis, and sideroblastic anemia)

See Also

• [Aminoacyl-tRNA synthetases](/search?type=gene&query=ARS)
• [Mitochondrial translation machinery](/mechanisms/mitochondrial-translation)
• [Charcot-Marie-Tooth disease genes](/search?type=gene&query=CMT)
• [Neurodevelopmental disorder genes](/search?type=gene&query=neurodevelopment)

External Links

• [Ensembl: ENSG00000124608](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000124608)
• [UniProt: P23381](https://www.uniprot.org/uniprotkb/P23381/entry)
• [OMIM: 191052](https://www.omim.org/entry/191052)